Corcept Therapeutics CORT reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Corcept Therapeutics beat estimated earnings by 66.67%, reporting an EPS of $0.35 versus an estimate of $0.21.
Revenue was up $13.09 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.1, which was followed by a 10.14% increase in the share price the next day.
Here's a look at Corcept Therapeutics's past performance:
|Quarter||Q3 2021||Q2 2021||Q1 2021||Q4 2020|
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.